UPDATE: HR 2239 did not pass in the 112th Congress. In February 2013, the Act was reintroduced in the 113th Congress as HR 842. Please see the March 2, 2013 post or click on the HR 842 category on the blog sidebar for updated information.
Congress is in session this week after the summer recess. As your Representatives return to Washington, DC, this is a good time to remind them of the need for research on IBS and other functional gastrointestinal or gastrointestinal motility disorders. HR 2239, the Functional Gastrointestinal and Motility Disorders Research Enhancement Act of 2011, is currently in the House of Representatives.
This bipartisan legislation’s lead sponsor is Representative F. James Sensenbrenner, Jr. (R-WI-5) and he has already been joined by co-sponsors, Representative James Moran (D-VA-8) and Representative Peter Welch (D-VT) If you are a constituent of any of these Representatives, please write or call to thank him for his support.
If you are a U.S. citizen residing elsewhere, and you have not contacted your own Representative yet, or you contacted him/her some time ago without receiving a response, please write or call to urge him/her to co-sponsor this important bill on behalf of people with IBS and/or other functional gastrointestinal or gastrointestinal motility disorders. For more information on this Act and how to help, please see IBS Impact’s previous blog posts from July 6 and August 1. or join IBS Impact.